Glimu MP 1mg/500mg/15mg Tablet
strip of 10.0 tablets.Prescription required
About this product:
| Salt Composition: | Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (5mg) |
| Manufacturer: | Grapple Life Sciences Pvt Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Glimu MP 1mg/500mg/15mg Tablet is a combination medicine that helps control blood sugar levels in adults with type 2 diabetes mellitus. Glimu MP 1mg/500mg/15mg Tablet is a combination medicine that helps control blood sugar levels. This medicine is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It helps in proper utilisation of insulin, thereby lowering the blood sugar levels.
Glimu MP 1mg/500mg/15mg Tablet is a combination of three antidiabetic medicines: Glimepiride, Metformin and Pioglitazone. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective.
Can I drink alcohol while taking Glimu MP 1mg/500mg/15mg Tablet?
No, drinking alcohol is not recommended while using Glimu MP 1mg/500mg/15mg Tablet. Alcohol may lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
What should I inform the doctor before taking Glimu MP 1mg/500mg/15mg Tablet?
Before taking Glimu MP 1mg/500mg/15mg Tablet, it is important to inform your doctor if you have: * Congestive heart failure * Kidney or liver problems * Swelling of the back of the eye. It is also crucial to inform your doctor if you are pregnant, breastfeeding, or a premenopausal woman. You should also let them know about any prescription and non-prescription medications, vitamins, or herbal supplements you may be taking.
Can the use of Glimu MP 1mg/500mg/15mg Tablet lead to Vitamin B12 deficiency?
Yes, the use of Glimu MP 1mg/500mg/15mg Tablet may cause vitamin B12 deficiency due to the presence of metformin in the medication. This drug can interfere with the absorption of vitamin B12 from the stomach over time.
Can the use of Glimu MP 1mg/500mg/15mg Tablet cause hypoglycemia?
Yes, the use of Glimu MP 1mg/500mg/15mg Tablet can lead to hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely to occur if you miss meals, drink alcohol, exercise excessively, or take other antidiabetic medicines with it. Therefore, regular monitoring of your blood sugar level is important. Always carry some sugary items like a candy or chocolate with you.
What are the instructions for the storage and disposal of Glimu MP 1mg/500mg/15mg Tablet?
Store this medicine in its original container, tightly closed. Follow the instructions on the packaging label or medication leaflet regarding storage requirements. Dispose of unused medication appropriately. Ensure it is not consumed by pets, children, or others.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimu MP 1mg/500mg/15mg Tablet is to be taken with food.
- Take it with food to lower your chance of having an upset stomach.
- It may cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines
- Always carry some sugary food or fruit juice with you in case you experience hypoglycemic symptoms such as cold sweats, cool pale skin, tremor, and anxiety.
- Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Alcohol
It is unsafe to consume alcohol with Glimu MP 1mg/500mg/15mg Tablet.
Breastfeed
Glimu MP 1mg/500mg/15mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Glimu MP 1mg/500mg/15mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby.
